News

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
On June 9, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr replaced all 17 ACIP members. 3 He noted that all of these members had been appointed by the Biden administration and said a ...
RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.
That decision came after discussions with the Food and Drug Administration, which is grappling with a massive overhaul under Health and Human Services Secretary ... Hoge said Covid, flu and ...
The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a ...
A newly approved shot could soon help protect babies from respiratory syncytial virus, the top cause of hospitalization in US infants.
By a 5-2 vote, the Advisory Committee on Immunization Practices endorsed Merck’s Enflonsia for babies born during or entering their first RSV season.